200 related articles for article (PubMed ID: 34261798)
1. Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer.
Chrysostomou S; Roy R; Prischi F; Thamlikitkul L; Chapman KL; Mufti U; Peach R; Ding L; Hancock D; Moore C; Molina-Arcas M; Mauri F; Pinato DJ; Abrahams JM; Ottaviani S; Castellano L; Giamas G; Pascoe J; Moonamale D; Pirrie S; Gaunt C; Billingham L; Steven NM; Cullen M; Hrouda D; Winkler M; Post J; Cohen P; Salpeter SJ; Bar V; Zundelevich A; Golan S; Leibovici D; Lara R; Klug DR; Yaliraki SN; Barahona M; Wang Y; Downward J; Skehel JM; Ali MMU; Seckl MJ; Pardo OE
Sci Transl Med; 2021 Jul; 13(602):. PubMed ID: 34261798
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of TRAF4 targeting RSK4 inhibits proliferation, invasion and metastasis in breast cancer xenografts.
Zhu L; Zhang S; Huan X; Mei Y; Yang H
Biochem Biophys Res Commun; 2018 Jun; 500(3):810-816. PubMed ID: 29684350
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of RSK4 reverses doxorubicin resistance in human breast cancer cells via PI3K/AKT signalling pathway.
Mei Y; Liao X; Zhu L; Yang H
J Biochem; 2020 Jun; 167(6):603-611. PubMed ID: 31960922
[TBL] [Abstract][Full Text] [Related]
4. Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells.
Thakur A; Sun Y; Bollig A; Wu J; Biliran H; Banerjee S; Sarkar FH; Liao DJ
Clin Cancer Res; 2008 Jul; 14(14):4427-36. PubMed ID: 18628456
[TBL] [Abstract][Full Text] [Related]
5. A Pilot Study of RSK4 Expression in Patients with Human Non-Small Cell Lung Carcinoma.
Li A; Liu D; Liu Y; Zhou Y; Du Z; Song J
Ann Clin Lab Sci; 2018 Jul; 48(4):484-489. PubMed ID: 30143490
[TBL] [Abstract][Full Text] [Related]
6. Differential Expression of RSK4 Transcript Isoforms in Cancer and Its Clinical Relevance.
Chen S; Seckl MJ; Lorentzen MPG; Pardo OE
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498899
[TBL] [Abstract][Full Text] [Related]
7. RSK4 knockdown promotes proliferation, migration and metastasis of human breast adenocarcinoma cells.
Zhu J; Li QY; Liu JL; Wei W; Yang HW; Tang W
Oncol Rep; 2015 Dec; 34(6):3156-62. PubMed ID: 26397146
[TBL] [Abstract][Full Text] [Related]
8. An siRNA screen identifies RSK1 as a key modulator of lung cancer metastasis.
Lara R; Mauri FA; Taylor H; Derua R; Shia A; Gray C; Nicols A; Shiner RJ; Schofield E; Bates PA; Waelkens E; Dallman M; Lamb J; Zicha D; Downward J; Seckl MJ; Pardo OE
Oncogene; 2011 Aug; 30(32):3513-21. PubMed ID: 21423205
[TBL] [Abstract][Full Text] [Related]
9. Aberrant methylation of the X-linked ribosomal S6 kinase RPS6KA6 (RSK4) in endometrial cancers.
Dewdney SB; Rimel BJ; Thaker PH; Thompson DM; Schmidt A; Huettner P; Mutch DG; Gao F; Goodfellow PJ
Clin Cancer Res; 2011 Apr; 17(8):2120-9. PubMed ID: 21372219
[TBL] [Abstract][Full Text] [Related]
10. Basic anatomy and tumor biology of the RPS6KA6 gene that encodes the p90 ribosomal S6 kinase-4.
Sun Y; Cao S; Yang M; Wu S; Wang Z; Lin X; Song X; Liao DJ
Oncogene; 2013 Apr; 32(14):1794-810. PubMed ID: 22614021
[TBL] [Abstract][Full Text] [Related]
11. Ribosomal S6 kinase 4 (RSK4) expression in ovarian tumors and its regulation by antineoplastic drugs in ovarian cancer cell lines.
Arechavaleta-Velasco F; Zeferino-Toquero M; Estrada-Moscoso I; Imani-Razavi FS; Olivares A; Perez-Juarez CE; Diaz-Cueto L
Med Oncol; 2016 Feb; 33(2):11. PubMed ID: 26732474
[TBL] [Abstract][Full Text] [Related]
12. [Effects of breast cancer cells stably overexpressing RSK4 on growth of transplanted human breast cancer in severe combined immunodeficiency mice].
Yang HW; Liu JL; Liao DZ; Sun Y; Chen ZS; Zhang XL
Zhonghua Yi Xue Za Zhi; 2012 Jul; 92(26):1845-8. PubMed ID: 22944237
[TBL] [Abstract][Full Text] [Related]
13. Prominent roles of ribosomal S6 kinase 4 (RSK4) in cancer.
Xu J; Jia Q; Zhang Y; Yuan Y; Xu T; Yu K; Chai J; Wang K; Chen L; Xiao T; Li M
Pathol Res Pract; 2021 Mar; 219():153374. PubMed ID: 33621918
[TBL] [Abstract][Full Text] [Related]
14. Effect of RSK4 on biological characteristics of colorectal cancer.
Ye Q; Wang X; Jin M; Wang M; Hu Y; Yu S; Yang Y; Yang J; Cai J
World J Surg Oncol; 2018 Dec; 16(1):240. PubMed ID: 30579335
[TBL] [Abstract][Full Text] [Related]
15. Ribosomal s6 protein kinase 4: a prognostic factor for renal cell carcinoma.
Fan L; Li P; Yin Z; Fu G; Liao DJ; Liu Y; Zhu J; Zhang Y; Wang L; Yan Q; Guo Y; Shao C; Huang G; Wang Z
Br J Cancer; 2013 Sep; 109(5):1137-46. PubMed ID: 23942078
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of the RSK4 promoter associated with BRAF V600E promotes papillary thyroid carcinoma.
Yin Y; Che K; Hu J; Hua H; Dong A; Wang J; Yu J; Zhang Q; Zhao S; Zhao Y; Wang P; Wang F; Wang Y; Chi J; Sun W
Int J Oncol; 2020 May; 56(5):1284-1293. PubMed ID: 32319586
[TBL] [Abstract][Full Text] [Related]
17. Frequent epigenetic inactivation of RSK4 by promoter methylation in cancerous and non-cancerous tissues of breast cancer.
Li Q; Jiang Y; Wei W; Ji Y; Gao H; Liu J
Med Oncol; 2014 Jan; 31(1):793. PubMed ID: 24338215
[TBL] [Abstract][Full Text] [Related]
18. Ribosomal S6 kinase 4 (RSK4) tumor suppressor gene promoter methylation status in ovarian cancer.
Arechavaleta-Velasco F; Dominguez-Lopez P; Acosta-Jimenez E; Diaz-Cueto L
Mol Biol Rep; 2023 Aug; 50(8):6863-6870. PubMed ID: 37402066
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of human RSK4, a new 90-kDa ribosomal S6 kinase, reveals constitutive activation in most cell types.
Dümmler BA; Hauge C; Silber J; Yntema HG; Kruse LS; Kofoed B; Hemmings BA; Alessi DR; Frödin M
J Biol Chem; 2005 Apr; 280(14):13304-14. PubMed ID: 15632195
[TBL] [Abstract][Full Text] [Related]
20. Ribosomal S6 protein kinase 4 promotes radioresistance in esophageal squamous cell carcinoma.
Li MY; Fan LN; Han DH; Yu Z; Ma J; Liu YX; Li PF; Zhao DH; Chai J; Jiang L; Li SL; Xiao JJ; Duan QH; Ye J; Shi M; Nie YZ; Wu KC; Liao DJ; Shi Y; Wang Y; Yan QG; Guo SP; Bian XW; Zhu F; Zhang J; Wang Z
J Clin Invest; 2020 Aug; 130(8):4301-4319. PubMed ID: 32396532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
